acetyl-11-ketoboswellic-acid and Leukemia--T-Cell

acetyl-11-ketoboswellic-acid has been researched along with Leukemia--T-Cell* in 1 studies

Other Studies

1 other study(ies) available for acetyl-11-ketoboswellic-acid and Leukemia--T-Cell

ArticleYear
Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:2

    Antiproliferative action of different pentacyclic triterpenes has repeatedly been reported, and some lipoxygenase inhibitors have been shown to induce cell death in various cell systems. Acetyl-11-keto-beta-boswellic acid (AKBA) is a pentacyclic triterpene that inhibits 5-lipoxygenase in a selective, enzymedirected, nonredox, and noncompetitive manner. To investigate a possible effect of AKBA on leukemic cell growth, proliferation of HL-60 and CCRF-CEM cells was assayed in the presence of AKBA and a structural analog without effect on 5-lipoxygenase, amyrin. Cell counts and [3H]thymidine incorporation were significantly reduced in a dose-dependent manner in the presence of AKBA (IC50 = 30 microM) but not amyrin. An additive effect of AKBA with the crosslinking of the CD95 receptor was also observed. Flow cytometric analysis of propidium iodide-stained cells indicated that the cells underwent apoptosis. This was confirmed by flow cytometric detection of sub-G1 peaks in AKBA-treated cells and by DNA laddering. However, because HL-60 and CCRF-CEM do not express 5-lipoxygenase mRNA constitutively, a mechanism distinct from inhibition of 5-lipoxygenase must account for the effect of AKBA. In a DNA relaxation assay with phiX174RF DNA, AKBA inhibited topoisomerase I from calf thymus at concentrations of >/=10 microM. A semiquantitative cDNA polymerase chain reaction approach was used to estimate the relative level of expression of topoisomerases in both cell lines. The data suggest that induction of apoptosis in HL-60 and CCRF-CEM by AKBA may be due to inhibition of topoisomerase I in these cells.

    Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Cell Division; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; HL-60 Cells; Humans; Isoenzymes; Leukemia, T-Cell; Lipoxygenase Inhibitors; Oleanolic Acid; Rats; RNA, Messenger; Topoisomerase I Inhibitors; Triterpenes; Tumor Cells, Cultured

1999